The New York Times

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results



Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.



Source link : https://www.nytimes.com/2024/11/25/health/cassava-alzheimers-simuflam.html

Author : Teddy Rosenbluth

Publish date : 2024-11-26 01:42:26

Copyright for syndicated content belongs to the linked Source.

Tags :The New York Times